Within-host virus evolution during the extended treatment of RSV infection with mutagenic drugs
View ORCID ProfileChristopher J. R. Illingworth, View ORCID ProfileAlexandra Y. Kreins, Adriana Margarit-Soler, Tim Best, Patricia Dyal, Giovanna Lucchini, Kanchan Rao, Rachel Williams, View ORCID ProfileAusten Worth, View ORCID ProfileJudith Breuer
doi: https://doi.org/10.1101/2022.09.02.22279474
Christopher J. R. Illingworth
1MRC-University of Glasgow Centre for Virus Research, Glasgow, United Kingdom
2Department of Applied Mathematics and Theoretical Physics, University of Cambridge, Cambridge, United Kingdom
Alexandra Y. Kreins
3Great Ormond Street Hospital for Children NHS Foundation Trust, London, UK
4Infection, Immunity and Inflammation Research and Teaching Department, University College London, London, UK
Adriana Margarit-Soler
3Great Ormond Street Hospital for Children NHS Foundation Trust, London, UK
Tim Best
3Great Ormond Street Hospital for Children NHS Foundation Trust, London, UK
Patricia Dyal
4Infection, Immunity and Inflammation Research and Teaching Department, University College London, London, UK
Giovanna Lucchini
3Great Ormond Street Hospital for Children NHS Foundation Trust, London, UK
Kanchan Rao
3Great Ormond Street Hospital for Children NHS Foundation Trust, London, UK
Rachel Williams
4Infection, Immunity and Inflammation Research and Teaching Department, University College London, London, UK
Austen Worth
3Great Ormond Street Hospital for Children NHS Foundation Trust, London, UK
Judith Breuer
3Great Ormond Street Hospital for Children NHS Foundation Trust, London, UK
4Infection, Immunity and Inflammation Research and Teaching Department, University College London, London, UK

Data Availability
Viral sequence data are available from the Sequence Read Archive with accession number PRJNA846693.
Posted September 18, 2022.
Within-host virus evolution during the extended treatment of RSV infection with mutagenic drugs
Christopher J. R. Illingworth, Alexandra Y. Kreins, Adriana Margarit-Soler, Tim Best, Patricia Dyal, Giovanna Lucchini, Kanchan Rao, Rachel Williams, Austen Worth, Judith Breuer
medRxiv 2022.09.02.22279474; doi: https://doi.org/10.1101/2022.09.02.22279474
Within-host virus evolution during the extended treatment of RSV infection with mutagenic drugs
Christopher J. R. Illingworth, Alexandra Y. Kreins, Adriana Margarit-Soler, Tim Best, Patricia Dyal, Giovanna Lucchini, Kanchan Rao, Rachel Williams, Austen Worth, Judith Breuer
medRxiv 2022.09.02.22279474; doi: https://doi.org/10.1101/2022.09.02.22279474
Subject Area
Subject Areas
- Addiction Medicine (410)
- Allergy and Immunology (725)
- Anesthesia (214)
- Cardiovascular Medicine (3086)
- Dermatology (260)
- Emergency Medicine (462)
- Epidemiology (13014)
- Forensic Medicine (13)
- Gastroenterology (860)
- Genetic and Genomic Medicine (4834)
- Geriatric Medicine (445)
- Health Economics (750)
- Health Informatics (3057)
- Health Policy (1101)
- Hematology (410)
- HIV/AIDS (956)
- Medical Education (453)
- Medical Ethics (119)
- Nephrology (499)
- Neurology (4606)
- Nursing (244)
- Nutrition (684)
- Oncology (2385)
- Ophthalmology (673)
- Orthopedics (268)
- Otolaryngology (333)
- Pain Medicine (300)
- Palliative Medicine (87)
- Pathology (514)
- Pediatrics (1239)
- Primary Care Research (520)
- Public and Global Health (7189)
- Radiology and Imaging (1601)
- Respiratory Medicine (943)
- Rheumatology (459)
- Sports Medicine (403)
- Surgery (509)
- Toxicology (65)
- Transplantation (221)
- Urology (189)